CalAmp downgraded by Craig-Hallum with a new price target
$CAMP
Craig-Hallum downgraded CalAmp from Buy to Hold and set a new price target of $10.00 from $14.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/5/2024 | Outperform | William Blair | |
| 11/5/2024 | $18.00 | Overweight | Piper Sandler |
| 11/5/2024 | $23.00 | Overweight | JP Morgan |
| 8/16/2022 | $8.00 → $10.00 | Hold → Buy | Craig Hallum |
| 12/22/2021 | $15.00 → $14.00 | Buy | Canaccord Genuity |
| 12/22/2021 | $14.00 → $10.00 | Buy → Hold | Craig-Hallum |
| 9/24/2021 | $16.00 → $14.00 | Buy | Craig Hallum |
| 6/25/2021 | $19.00 → $18.50 | Buy | Roth Capital |
10-Q - Camp4 Therapeutics Corp (0001736730) (Filer)
8-K - Camp4 Therapeutics Corp (0001736730) (Filer)
S-8 - Camp4 Therapeutics Corp (0001736730) (Filer)
William Blair initiated coverage of CAMP4 Therapeutics with a rating of Outperform
Piper Sandler initiated coverage of CAMP4 Therapeutics with a rating of Overweight and set a new price target of $18.00
JP Morgan initiated coverage of CAMP4 Therapeutics with a rating of Overweight and set a new price target of $23.00
- Completed Initial Public Offering (IPO) of common stock, raising gross proceeds of $82.1M- Single Ascending Dose (SAD) portion of Phase 1 study of CMP-CPS-001 completed; safety data anticipated in Q1 2025- Entered strategic research collaboration with BioMarin valued at over $370M CAMBRIDGE, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4") (NASDAQ:CAMP), a clinical-stage biotechnology company developing a pipeline of regRNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels across a range of genetic diseases, today reported financial results for the third quarter ended September 30, 2024, and p
CAMBRIDGE, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4") (NASDAQ:CAMP), a clinical-stage biotechnology company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels across a range of genetic diseases, today announced the pricing of its initial public offering of 6,820,000 shares of its common stock at an initial public offering price of $11.00 per share. All of the shares are being offered by CAMP4. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $75.0
Lynrock to become the principal equity owner and take CalAmp private Continues to operate business as usual throughout this process Enhanced liquidity to invest in innovation to support customers' evolving needs IRVINE, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- CalAmp (NASDAQ:CAMP), a connected intelligence company helping people and organizations improve operational performance with a data-driven solutions ecosystem, today announced that it has entered into a Restructuring Support Agreement ("RSA") with its principal secured lender, Lynrock Lake Master Fund LP ("Lynrock"), who will become the principal equity owner of CalAmp and take the Company private. In a strategi
4/A - Camp4 Therapeutics Corp (0001736730) (Issuer)
3/A - Camp4 Therapeutics Corp (0001736730) (Issuer)
4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
4/A - Camp4 Therapeutics Corp (0001736730) (Issuer)
4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
4 - Camp4 Therapeutics Corp (0001736730) (Issuer)
IRVINE, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- CalAmp (NASDAQ:CAMP), a connected intelligence company that helps organizations monitor, track and protect their vital assets, today reported financial results for its third quarter of fiscal year 2024 ended November 30, 2023. Third Quarter Fiscal Year 2024 Financial Overview Revenue was $53.6 million, representing a 13% decline QoQ and a 32% decline YoY driven primarily by softer demand in the TSP market segment.Gross margin was 33%, representing a decline of approximately 340 bps QoQ and 100 bps decline YoY as a result of a shift in product mix and a higher-than-normal reserve for excess and obsolete inventory.S&SS revenue was $34.5
IRVINE, Calif., Dec. 26, 2023 (GLOBE NEWSWIRE) -- CalAmp (NASDAQ:CAMP), a leading telematics solution provider that helps organizations improve operational performance, today announced that it will release its fiscal 2024 third quarter financial results after market close on Tuesday, January 9, 2024. In addition, the Company will host a conference call at 5:00 p.m. Eastern (2:00 p.m. Pacific) on January 9, 2024, to discuss its financial results. The call may be accessed via webcast by visiting the Investor Relations section of CalAmp's website at CalAmp IR Web Site. Please go to the website at least 15 minutes early to register, download and install any necessary audio software. A repla
IRVINE, Calif., Dec. 18, 2023 (GLOBE NEWSWIRE) -- CalAmp (NASDAQ:CAMP), a connected intelligence company helping people and organizations improve operational performance with telematics solutions, today announced the closing of a $45 million strategic financing with Lynrock Lake Master Fund LP ("Lynrock") in the form of a term loan maturing in November 2027. Lynrock is an existing holder of a large majority of CalAmp's 2.00% Convertible Senior Notes maturing in August 2025 (the "Notes"). In connection with the execution of the term loan agreement, CalAmp is amending the Notes to add a security interest. "As a long-standing investor in CalAmp, we are pleased to provide the company with add
SC 13G - Camp4 Therapeutics Corp (0001736730) (Subject)
SC 13D - Camp4 Therapeutics Corp (0001736730) (Subject)
SC 13G - Camp4 Therapeutics Corp (0001736730) (Subject)
IRVINE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- CalAmp (NASDAQ:CAMP), a connected intelligence company helping people and organizations improve operational performance with telematics solutions, is pleased to announce that Chris Adams will be joining the company as President and Chief Executive Officer (CEO), effective January 22, 2024. Adams is an accomplished technology leader who brings a wealth of knowledge and experience to CalAmp. He possesses a unique combination of technical depth, operational skills, and general management experience from a broad range of technology companies – most recently as VP/GM of the Automotive Sensing Division at onsemi. "After a comprehensiv
IRVINE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- CalAmp (NASDAQ:CAMP), a connected intelligence company helping people and organizations improve operational performance with a data-driven solutions ecosystem, today announced that Jeff Gardner will be stepping down from his role as Chief Executive Officer, effective no later than October 30, 2023. The Company has commenced a search for its next CEO and will be retaining an executive search firm. In announcing his departure, Jeff Gardner shared, "It has been a privilege working with the amazing group of colleagues at CalAmp. I am proud of all that we have accomplished and the progress we have made in positioning the Company for growth and p
IRVINE, Calif., Dec. 02, 2022 (GLOBE NEWSWIRE) -- CalAmp (NASDAQ:CAMP), a connected intelligence company that helps people and organizations improve operational performance, today announced that effective January 9, 2023, Jikun Kim, 58, will commence employment as Senior Vice President and Chief Financial Officer of CalAmp Corp. (the "Company"). Mr. Kim will serve as principal financial officer and principal accounting officer. Xiaolian (Cindy) Zhang will cease service as Interim Chief Financial Officer, and will continue to serve as Senior Vice President, Financial Planning and Analysis, and Erik Schulz will cease service as Interim Principal Accounting Officer, and will continue to serve
Gainers FOXO Technologies (AMEX:FOXO) stock increased by 21.8% to $0.33 during Tuesday's after-market session. The market value of their outstanding shares is at $3.5 million. Oracle (NYSE:ORCL) stock moved upwards by 8.02% to $133.82. The company's market cap stands at $367.8 billion. As per the press release, Q4 earnings came out today. U-BX Technology (NASDAQ:UBXG) stock rose 7.57% to $12.5. The market value of their outstanding shares is at $337.5 million. EMCORE (NASDAQ:EMKR) shares moved upwards by 7.27% to $0.87. The company's market cap stands at $7.2 million. Rubrik (NYSE:RBRK) shares rose 5.64% to $37.25. The company's market cap stands at $6.5 billion. As per the news, the Q1
Shares of Contango Ore, Inc. (NYSE:CTGO) fell sharply during Tuesday's session after the company announced pricing of $15 million underwritten public offering. Contango Ore shares dipped 18.4% to $20.34 on Tuesday. Here are some other stocks moving in today’s mid-day session. Gainers Trio Petroleum Corp. (NYSE:TPET) shares jumped 88.2% to $0.4254 after the company completed its first two exploratory wells. Airship AI Holdings, Inc. (NASDAQ:AISP) shares climbed 32.5% to $4.1599. Airship AI announced a six-figure sole-source contract award within the Department of Justice for Acropolis Enterprise Video and Data Management Platform. Blue World Acquisition Corporation (NASDAQ
Gainers U-BX Technology (NASDAQ:UBXG) stock increased by 61.4% to $15.3 during Tuesday's regular session. The market value of their outstanding shares is at $413.0 million. Airship AI Holdings (NASDAQ:AISP) shares rose 47.13% to $4.62. The market value of their outstanding shares is at $106.9 million. Mercurity Fintech Holding (NASDAQ:MFH) stock rose 23.11% to $1.97. The market value of their outstanding shares is at $119.8 million. Sonim Technologies (NASDAQ:SONM) stock increased by 16.77% to $0.64. The market value of their outstanding shares is at $30.0 million. Quantum (NASDAQ:QMCO) stock rose 13.21% to $0.49. The company's market cap stands at $46.7 million. GCT Semiconductor Hldg